Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.
Oscar HealthLemonade

Oscar Health vs Lemonade

This page compares Oscar Health, Inc. and Lemonade, Inc., outlining how each company structures its business model, how its financial performance has been framed, and the market context in which it op...

Investment Analysis

Pros

  • Oscar Health reported robust revenue growth with over 2 million members and is close to achieving its first full year of GAAP profitability.
  • The company has demonstrated improved cost control and rising margins, shifting from a high-potential start-up to a more efficient operator.
  • Despite a premium valuation, Oscar’s low price-to-sales ratio suggests potential for further re-rating if profitability proves sustainable.

Considerations

  • Oscar remains exposed to regulatory and reimbursement risks inherent in the US health insurance sector, which could pressure margins and growth.
  • The stock’s valuation multiples are elevated relative to earnings, reflecting high investor expectations for continued execution and profitability.
  • Oscar’s business is concentrated solely in health insurance, limiting diversification compared to peers with broader product portfolios.

Pros

  • Lemonade continues to post accelerating premium and revenue growth, expanding its customer base and product lines across multiple geographies.
  • The company has significantly improved loss and gross margins, generating positive adjusted free cash flow and expecting further profitability milestones.
  • Lemonade’s AI-driven platform differentiates its customer experience and supports rapid scaling in new insurance categories and markets.

Considerations

  • Lemonade remains unprofitable on a net income basis, with continued cash burn and a valuation that is sensitive to any growth or execution setbacks.
  • The stock exhibits high volatility and has recently traded far above average analyst price targets, raising valuation concerns.
  • Intense competition and the capital-intensive nature of insurance underwriting may challenge sustained margin improvement and cash generation.

Which Baskets Do They Appear In?

No baskets available in this category

Buy OSCR or LMND in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Comparisons

Oscar HealthSelective

Oscar Health vs Selective

Oscar Health vs Selective: business comparison

Oscar HealthUpstart

Oscar Health vs Upstart

Oscar Health vs Upstart

Oscar HealthLazard

Oscar Health vs Lazard

Oscar Health vs Lazard

Frequently asked questions